• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磺胺嘧啶/甲氧苄啶每日一次治疗上颌窦炎:与磺胺甲恶唑/甲氧苄啶每日两次治疗的随机双盲对照研究

Sulphadiazine/trimethoprim once daily in maxillary sinusitis: a randomized double-blind comparison with sulphamethoxazole/trimethoprim B.I.D.

作者信息

Federspil P, Bamberg P

出版信息

J Int Med Res. 1981;9(6):478-81. doi: 10.1177/030006058100900609.

DOI:10.1177/030006058100900609
PMID:7033013
Abstract

In a randomized double-blind study fifty-four patients suffering from acute maxillary sinusitis were treated for 10 days with daily doses of sulphadiazine/trimethoprim (1 g) and sulphamethoxazole/trimethoprim (1.92 g), respectively. The efficacy was evaluated clinically at two follow-up visits. X-ray investigations were performed at admission and after the therapy. Of thirty-nine patients finally evaluated, thirty-seven showed a favourable result. After 6-8 days of therapy there was significant difference in cure rates in favour of sulphadiazine/trimethoprim (p less than 0.05) while the outcome as evaluated after treatment was similar for both drugs.

摘要

在一项随机双盲研究中,54例急性上颌窦炎患者分别接受了为期10天的磺胺嘧啶/甲氧苄啶(每日剂量1克)和磺胺甲恶唑/甲氧苄啶(每日剂量1.92克)治疗。在两次随访中对疗效进行了临床评估。在入院时和治疗后进行了X线检查。在最终评估的39例患者中,37例显示出良好的结果。治疗6 - 8天后,磺胺嘧啶/甲氧苄啶的治愈率有显著差异(p小于0.05),而两种药物治疗后的评估结果相似。

相似文献

1
Sulphadiazine/trimethoprim once daily in maxillary sinusitis: a randomized double-blind comparison with sulphamethoxazole/trimethoprim B.I.D.磺胺嘧啶/甲氧苄啶每日一次治疗上颌窦炎:与磺胺甲恶唑/甲氧苄啶每日两次治疗的随机双盲对照研究
J Int Med Res. 1981;9(6):478-81. doi: 10.1177/030006058100900609.
2
Comparison of trimethoprim in combination with sulfadiazine or sulfamethoxazole in the treatment of urinary tract infections.甲氧苄啶联合磺胺嘧啶或磺胺甲恶唑治疗尿路感染的比较。
J Postgrad Med. 1981 Jul;27(3):154-8.
3
Double-blind comparative trial of trimethoprim/sulfamethopyrazine once daily vs erythromycin 4 X daily in patients with ENT infections.在耳鼻喉感染患者中,每日一次甲氧苄啶/磺胺甲吡嗪与每日4次红霉素的双盲对照试验。
Int J Clin Pharmacol Ther Toxicol. 1983 Oct;21(10):535-9.
4
Comparison of sulphadiazine-trimethoprim and sulphamethoxazole-trimethoprim in the treatment of acute respiratory tract infections. Randomized double-blind trial.磺胺嘧啶-甲氧苄啶与磺胺甲恶唑-甲氧苄啶治疗急性呼吸道感染的比较。随机双盲试验。
Chemotherapy. 1980;26(4):297-300. doi: 10.1159/000237920.
5
Comparison of pharmacokinetics of sulphadiazine and sulphamethoxazole after intravenous infusion.静脉输注后磺胺嘧啶和磺胺甲恶唑的药代动力学比较。
J Antimicrob Chemother. 1982 Jun;9(6):461-70. doi: 10.1093/jac/9.6.461.
6
[Clinical evaluation of co-tetroxazine in acute purulent sinusitis and acute tonsillitis in a double-blind comparison].[双盲比较中co - 四氧嗪治疗急性化脓性鼻窦炎和急性扁桃体炎的临床评价]
Wien Klin Wochenschr. 1984 Mar 16;96(6):219-25.
7
[Clinical study of sulfamethoxazole trimethoprim in ENT for suppurative otitis and rhinosinusitis].复方磺胺甲恶唑在耳鼻喉科治疗化脓性中耳炎和鼻窦炎的临床研究
Rev Laryngol Otol Rhinol (Bord). 1978 Jan-Feb;99(1-2):157-8.
8
Trimethoprim-sulfamethoxazole for acute dysuria in women: a single-dose or 10-day course. A double-blind, randomized trial.甲氧苄啶-磺胺甲恶唑治疗女性急性排尿困难:单剂量或10天疗程。一项双盲随机试验。
Ann Intern Med. 1988 Mar;108(3):350-7. doi: 10.7326/0003-4819-108-3-350.
9
Comparison of once daily trimethoprim and standard co-trimoxazole in urinary infections. A clinical trial in general practice.每日一次服用甲氧苄啶与标准复方新诺明治疗泌尿系统感染的比较。一项全科医疗中的临床试验。
Practitioner. 1982 Jan;226(1363):152-6.
10
A comparison of co-trimazine once daily and co-trimoxazole twice daily in treatment of urinary tract infections in children.每日一次的复方磺胺嘧啶与每日两次的复方新诺明治疗儿童尿路感染的比较。
J Antimicrob Chemother. 1982 Nov;10(5):453-8. doi: 10.1093/jac/10.5.453.

引用本文的文献

1
Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.复方新诺明(甲氧苄啶-磺胺甲恶唑):抗菌活性及临床疗效的最新综述
Drugs. 1982 Dec;24(6):459-518. doi: 10.2165/00003495-198224060-00002.